Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
869.2000 -5.90 (-0.67%)
NSE Jun 23, 2025 15:31 PM
Volume: 353.3K
 

logo
Natco Pharma Ltd.
08 Aug 2017
869.20
-0.67%
buy
Results Update: Natco Pharma Ltd.
by HDFC Securities
HDFC Securities
Revenue decreased by 25.91% to Rs. 428.1 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 25.91% to Rs. 428.1 Cr in Q1FY18 when compared to the previous quarter.
 
Natco Pharma Ltd. has an average target of 1297.50 from 4 brokers.
More from Natco Pharma Ltd.
Recommended
IPOs This Week: Arisinfra and Five Others to List; Eighteen New Issues
| 23 Jun 2025, 04:49PM
Market closes lower, ideaForge bags a Rs 137 crore order from MoD to supply mini UAVs
Trendlyne Marketwatch | 23 Jun 2025, 04:05PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
| 18 Jun 2020